Nasdaq Stockholm AB has assessed that Cinclus Pharma Holding AB, company registration number 559136-8765, fulfills Nasdaq Stockholm's listing requirements. Provided that Cinclus Pharma Holding AB applies for admission to trading of its shares on Nasdaq Stockholm, and that the liquidity requirements are met, first day of trading is expected to June 20, 2024. As per today's date the company has a total of 26,227,040 shares. Short Name: CINPHA ---------------------------------------------------------------- ISIN Code: SE0020388577 ---------------------------------------------------------------- Order book id: 335514 ---------------------------------------------------------------- Maximum number of shares to be listed: 46,537,789 ---------------------------------------------------------------- Clearing: CCP Cleared ---------------------------------------------------------------- Segment: Mid cap ---------------------------------------------------------------- Market segment: STO Equities CCP/182 ---------------------------------------------------------------- Tick Size Table: MiFID II tick size table ---------------------------------------------------------------- MIC: XSTO ---------------------------------------------------------------- ICB Classification: Industry code: 20 Health Care ----------------------------------- Supersector code: 2010 Health Care ----------------------------------- When issued trading Trading will be on a when issued basis from June 20 up and including June 24, 2024, i.e. trading will begin before all conditions in the offering have been fulfilled and will cease if the offering is not completed. For further information see pages 33 and 132-133 in the prospectus. For further information concerning this exchange notice please contact Listing Qualifications, telephone +46 8 405 72 80 or iss@nasdaq.com.
Aktien»Nachrichten»CINCLUS PHARMA AKTIE»Nasdaq Stockholm AB: Listing of Cinclus Pharma Holding AB on Nasdaq Stockholm
Nasdaq Stockholm AB: Listing of Cinclus Pharma Holding AB on Nasdaq Stockholm
© 2024 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.06. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 21.06.2024 | The following instruments on XETRA do have their first trading 21.06.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 21.06.2024
Aktien
1 US0097071007 Ajinomoto Co. Inc. ADR
2... ► Artikel lesen | |
| 20.06. | TRILL IMPACT AB: Trading in Trill Impact's portfolio company Cinclus Pharma commences on Nasdaq Stockholm | ||
| 20.06. | Nasdaq Stockholm welcomes Cinclus Pharma to the Main Market | Stockholm, Jun 20, 2024 - Nasdaq (Nasdaq: NDAQ) announces that trading in the
shares of Cinclus Pharma Holding AB (ticker name: CINPHA) will commence today
on the Nasdaq Stockholm Main Market. Cinclus... ► Artikel lesen | |
| 20.06. | Cinclus Pharma Holding AB: First day of trading in Cinclus Pharma's ordinary shares on Nasdaq Stockholm | Cinclus Pharma Holding AB (publ) ("Cinclus Pharma" or the "Company"), a Swedish clinical stage pharmaceutical company, today announces the outcome of the offering of newly issued ordinary shares (the... ► Artikel lesen | |
| 19.06. | Nasdaq Stockholm AB: Listing of Cinclus Pharma Holding AB on Nasdaq Stockholm | On request of Cinclus Pharma Holding AB, company registration number
559136-8765, Nasdaq Stockholm has admitted the company's shares to trading
with effect from June 20, 2024. The decision is conditional... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
